Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. (2019)
Attributed to:
The evolutionary dynamics of multiazole resistance in pathogenic Aspergillus fungi
funded by
NERC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkz075
PubMed Identifier: 30805605
Publication URI: http://europepmc.org/abstract/MED/30805605
Type: Journal Article/Review
Volume: 74
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 6
ISSN: 0305-7453